[go: up one dir, main page]

GB2235627B - Inhalation medicaments for treating respiratory disorders - Google Patents

Inhalation medicaments for treating respiratory disorders

Info

Publication number
GB2235627B
GB2235627B GB9019659A GB9019659A GB2235627B GB 2235627 B GB2235627 B GB 2235627B GB 9019659 A GB9019659 A GB 9019659A GB 9019659 A GB9019659 A GB 9019659A GB 2235627 B GB2235627 B GB 2235627B
Authority
GB
United Kingdom
Prior art keywords
respiratory disorders
treating respiratory
inhalation medicaments
medicaments
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
GB9019659A
Other versions
GB9019659D0 (en
GB2235627A (en
Inventor
James Barry Douglas Palmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27264676&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2235627(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB898920392A external-priority patent/GB8920392D0/en
Priority claimed from GB898923644A external-priority patent/GB8923644D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB9019659A priority Critical patent/GB2235627B/en
Publication of GB9019659D0 publication Critical patent/GB9019659D0/en
Publication of GB2235627A publication Critical patent/GB2235627A/en
Application granted granted Critical
Publication of GB2235627B publication Critical patent/GB2235627B/en
Priority to CY181795A priority patent/CY1817A/en
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9019659A 1989-09-08 1990-09-07 Inhalation medicaments for treating respiratory disorders Revoked GB2235627B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB9019659A GB2235627B (en) 1989-09-08 1990-09-07 Inhalation medicaments for treating respiratory disorders
CY181795A CY1817A (en) 1989-09-08 1995-10-20 Inhalation medicaments for treating respiratory disorders

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898920392A GB8920392D0 (en) 1989-09-08 1989-09-08 Medicaments
GB898923644A GB8923644D0 (en) 1989-10-20 1989-10-20 Medicaments
GB9019659A GB2235627B (en) 1989-09-08 1990-09-07 Inhalation medicaments for treating respiratory disorders

Publications (3)

Publication Number Publication Date
GB9019659D0 GB9019659D0 (en) 1990-10-24
GB2235627A GB2235627A (en) 1991-03-13
GB2235627B true GB2235627B (en) 1993-09-01

Family

ID=27264676

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9019659A Revoked GB2235627B (en) 1989-09-08 1990-09-07 Inhalation medicaments for treating respiratory disorders

Country Status (2)

Country Link
CY (1) CY1817A (en)
GB (1) GB2235627B (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US6792945B2 (en) 1990-03-02 2004-09-21 Glaxo Group Limited Inhalation device
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7225808B2 (en) 1990-03-02 2007-06-05 Glaxo Group Limited Inhalation device
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270305A (en) 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
EP0616524B1 (en) 1991-12-12 1998-10-07 Glaxo Group Limited Medicaments
IL104068A (en) † 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
DE60031504T2 (en) 1999-09-11 2007-04-05 Glaxo Group Ltd., Greenford FLUTICASONPROPIONATE DRUG PREPARATION
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
GB0124523D0 (en) * 2001-10-12 2001-12-05 Glaxo Group Ltd Pharmaceutical combination
JP2007528889A (en) * 2004-03-12 2007-10-18 シプラ・リミテッド Inhalation formulation
EP2120875B1 (en) 2007-02-11 2018-07-11 Map Pharmaceuticals Inc. Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6536427B2 (en) 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US6792945B2 (en) 1990-03-02 2004-09-21 Glaxo Group Limited Inhalation device
US7225808B2 (en) 1990-03-02 2007-06-05 Glaxo Group Limited Inhalation device
US7389775B2 (en) 1990-03-02 2008-06-24 Glaxo Group Limited Inhalation device
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials

Also Published As

Publication number Publication date
CY1817A (en) 1995-10-20
GB9019659D0 (en) 1990-10-24
GB2235627A (en) 1991-03-13

Similar Documents

Publication Publication Date Title
HU9401742D0 (en) Medicaments for inhalation
GB8924823D0 (en) Dosage inhalers
IL101289A0 (en) Inhaler for solid medicaments
AU2250788A (en) Respiratory mask
GB9017230D0 (en) Circulatory respiratory protective apparatus
GB8706200D0 (en) Respiratory mask
IL116492A0 (en) Therapeutic preparations for inhalation
GB2235627B (en) Inhalation medicaments for treating respiratory disorders
HU913680D0 (en) Inhaling apparatus, primarily for powdered medicaments
GB2264235B (en) Composition for nasal treatment
GB2218640B (en) Medical breathing apparatus
GB8723984D0 (en) Respiratory protective apparatus
GB2234440B (en) Respiratory protective apparatus
GB8911259D0 (en) Inhalation medicament
GB2190000B (en) Inhalation therapy unit
GB8928508D0 (en) Circulatory respiratory protective apparatus
ZA86365B (en) Use of sulphanyldihydropyridines as medicaments for the treatment of asthma
PL284056A1 (en) Inhaler for nasal inhalations
BG96235A (en) Medicament for treating the upper respiratory tracts
GB8914225D0 (en) Medicament inhalation device
GB8922012D0 (en) Composition for treatment of respiratory ailments
ZA944378B (en) Therapeutic preparation for inhalation
GB8900268D0 (en) Inhalation devices having dosage control
CA71422S (en) Medicament inhalation device
PHUM7561Z (en) A therapeutic composition for the treatment of asthma

Legal Events

Date Code Title Description
CTFF Supplementary protection certificate filed

Free format text: SPC/GB99/016, 19990406

CTFG Supplementary protection certificate granted

Free format text: SPC/GB99/016, 19990902, EXPIRES: 20130906

7722 Petition lodged in court (sect. 72/1977)
772R Patent revoked (sect. 72/1977)
772R Patent revoked (sect. 72/1977)
775E Patent revoked (sect. 75/1977)
CTFI Supplementary protection certificate declared invalid

Free format text: SPC/GB99/016: 20040405

Spc suppl protection certif: SPC/GB99/016

Filing date: 20040405